Status:
COMPLETED
Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Endometriosis Ovary
Eligibility:
FEMALE
18+ years
Brief Summary
Medical treatment of endometriosis has a suspensive and sometimes incomplete effect on the symptoms, making surgical treatment necessary. The aim of surgical treatment of deep endometriosis is to rest...
Eligibility Criteria
Inclusion
- Adult woman (≥18 years old)
- Patient who benefited from treatment by nerve-sparing surgery and the use of neutral argon plasma in the context of symptomatic deep pelvic endometriosis at the Strasbourg University Hospital during 2021
- Patient who did not express, after information, the reuse of her data for the purposes of this research.
Exclusion
- Patient who expressed her opposition to participating in the study
- Patient under legal protection, under guardianship or under curatorship
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06207448
Start Date
April 1 2022
End Date
June 6 2022
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie Obstétrique - CHU de Strasbourg - France
Strasbourg, France, 67091